3 doses of HPV 16/18 bivalent vaccine

PROCEDURE2 trials

Sponsors

Jun Zhang

Conditions

Cervical CancerCervical Intraepithelial NeoplasiaPersistent InfectionVaginal Intraepithelial NeoplasiaVulvar Intraepithelial Neoplasia

Phase 3

A Bridging Study of a Recombinant Human Papillomavirus 16/18 Bivalent Vaccine in Preadolescent Girls

CompletedNCT02562508

Jun ZhangCervical Cancer, Cervical Intraepithelial Neoplasia, Persistent Infection +2

Start: 2015-12-05End: 2016-08-12Updated: 2018-08-16

Unknown Phase

Immuno-persistence Study of a Recombinant Human Papillomavirus 16/18 Bivalent Vaccine in Preadolescent Girls

CompletedNCT03206255

Jun ZhangCervical Cancer, Cervical Intraepithelial Neoplasia, Persistent Infection +2

Start: 2017-07-01End: 2018-08-15Updated: 2019-01-04

Related Papers

Long-Term immunopersistence and safety of the <i>Escherichia coli</i> -produced HPV-16/18 bivalent vaccine in Chinese adolescent girls

Human Vaccines & Immunotherapeutics2022-04-135 citations